520 results on '"Denis, Cécile V."'
Search Results
102. Potent Thrombolytic Effect of N -Acetylcysteine on Arterial Thrombi
103. Unique humanized mouse models of von Willebrand disease type 2A.
104. Network-based analysis of omics data: the LEAN method
105. LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B
106. Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M
107. Platelet Functions are Decreased in Obesity and Restored after Weight Loss: Evidence for a Role of the SERCA3-Dependent ADP Secretion Pathway.
108. The Von Willebrand Factor Tyr2561 Allele Is a Gain-of-Function Variant and a Potential Risk Factor for Early Myocardial Infarction
109. Antibody-Based Protection of von Willebrand Factor Degradation
110. Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis
111. A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation
112. A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease
113. Von Willebrand Factor Abnormalities Studied in the Mouse Model: What We Learned about VWF Functions
114. ON THE VERSATILITY OF VON WILLEBRAND FACTOR
115. A mutation of the human EPHB2gene leads to a major platelet functional defect
116. Platelet Desialylation Is a Novel Mechanism of Thrombocytopenia during Mechanical Circulatory Assistance
117. Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis
118. Of von Willebrand factor and platelets
119. Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.
120. Network-based analysis of omics data: the LEAN method.
121. Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm
122. Expression of a structurally constrained von Willebrand factor variant triggers acute thrombotic thrombocytopenic purpura in mice
123. GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice
124. Blocking Von Willebrand Factor for Treatment of Cutaneous Inflammation
125. Platelet von Willebrand factor: sweet resistance
126. Integrin α 6 β 1 Is the Main Receptor for Vascular Laminins and Plays a Role in Platelet Adhesion, Activation, and Arterial Thrombosis
127. Determinants of von Willebrand Factor Function
128. Mechanisms and Therapeutic Modulation of the Bleeding Tendency in Genetically-Engineered Von Willebrand Disease Type 2B Mice
129. Coagulation Factor X Interaction with Macrophages through Its N-Glycans Protects It from a Rapid Clearance
130. Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand Factor
131. MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation
132. A nanobody against the von Willebrand factor A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired von Willebrand disease
133. Animal Models in von Willebrand Disease
134. Novel Function of Tenascin-C, a Matrix Protein Relevant to Atherosclerosis, in Platelet Recruitment and Activation Under Flow
135. Siglecs as Novel Cellular Partners for Von Willebrand Factor
136. Binding of von Willebrand Factor to Collagen and Glycoprotein Ibα, But Not to Glycoprotein IIb/IIIa, Contributes to Ischemic Stroke in Mice—Brief Report
137. In vivo MRI and ex vivo quantification of iron and Kupffer cells demonstrate residual phagocytic activity in mouse liver after a gadolinium chloride injection
138. Efficient Inhibition of Collagen-Induced Platelet Activation and Adhesion by LAIR-2, a Soluble Ig-Like Receptor Family Member
139. Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients
140. Cellular uptake of C4b-binding protein is mediated by heparan sulfate proteoglycans and CD91/LDL receptor-related protein
141. Correction of Bleeding Symptoms in von Willebrand Factor–Deficient Mice by Liver-Expressed von Willebrand Factor Mutants
142. Clearance of von Willebrand factor
143. Platelet Adhesion Receptors and Their Ligands in Mouse Models of Thrombosis
144. Correction of the bleeding time in von Willebrand factor (VWF)–deficient mice using murine VWF
145. O-Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels.
146. Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels
147. In Vivo Clearance of Human Protein S in a Mouse Model
148. An Experimental Model to Study the in Vivo Survival of von Willebrand Factor
149. Von Willebrand factor in vascular pathophysiology
150. The Clearance Mechanism of Chilled Blood Platelets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.